These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 37682937)

  • 1. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
    Yousif FA; Alzain AA; Alraih AM; Ibraheem W
    PLoS One; 2023; 18(9):e0291256. PubMed ID: 37682937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual Screening for Identification of Dual Inhibitors against CDK4/6 and Aromatase Enzyme.
    Adon T; Shanmugarajan D; Ather H; Ansari SMA; Hani U; Madhunapantula SV; Honnavalli YK
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual aromatase-steroid sulfatase inhibitors (DASI's) for the treatment of breast cancer: a structure guided ligand based designing approach.
    Singh Y; Jaswal S; Singh S; Verma SK; Thareja S
    J Biomol Struct Dyn; 2023 Dec; 41(20):10604-10626. PubMed ID: 36510679
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Bouricha EM; Hakmi M; Akachar J; Zouaidia F; Ibrahimi A
    J Biomol Struct Dyn; 2022 Jul; 40(11):5203-5210. PubMed ID: 33402049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations.
    Susanti NMP; Damayanti S; Kartasasmita RE; Tjahjono DH
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repositioning of experimentally validated anti-breast cancer peptides to target FAK-PAX complex to halt the breast cancer progression: a biomolecular simulation approach.
    Khan A; Shan S; Toor TF; Suleman M; Wang Y; Zhou J; Wei DQ
    Mol Divers; 2023 Apr; 27(2):603-618. PubMed ID: 35635599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
    Awasthi M; Singh S; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling cell proliferation by targeting cyclin-dependent kinase 6 using drug repurposing approach.
    Madhana Priya N; Balasundaram A; Sidharth Kumar N; Udhaya Kumar S; Thirumal Kumar D; Magesh R; Zayed H; George Priya Doss C
    Adv Protein Chem Struct Biol; 2023; 135():97-124. PubMed ID: 37061342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Novel Letrozole Analogues Targeting Aromatase for Breast Cancer: Molecular Docking, Molecular Dynamics, and Theoretical Studies on Gold Nanoparticles.
    Edris A; Abdelrahman M; Osman W; Sherif AE; Ashour A; Garelnabi EAE; Ibrahim SRM; Bafail R; Samman WA; Ghazawi KF; Mohamed GA; Alzain AA
    Metabolites; 2023 Apr; 13(5):. PubMed ID: 37233624
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Maruthanila VL; Elancheran R; Mirunalini S
    Curr Comput Aided Drug Des; 2022; 18(3):196-212. PubMed ID: 35598239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based pharmacophore modeling for precision inhibition of mutant ESR2 in breast cancer: A systematic computational approach.
    Islam S; Amin MA; Rengasamy KRR; Mohiuddin AKM; Mahmud S
    Cancer Med; 2024 Aug; 13(15):e70074. PubMed ID: 39101505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study.
    Alghamdi S; Baeissa HM; Azhar Kamal M; Rafeeq MM; Al Zahrani A; Maslum AA; Hakeem IJ; Alazragi RS; Alam Q
    J Biomol Struct Dyn; 2024 Oct; 42(16):8268-8280. PubMed ID: 37599470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.
    Almasoudi HH; Hakami MA; Alhazmi AY; Makkawi M; Alasmari S; Alghamdi YS; Mashraqi MM
    Med Oncol; 2023 Jul; 40(8):218. PubMed ID: 37394519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New enantioenriched Ī²-indolyl ketones as aromatase inhibitors: Unraveling heme-ligand interactions by MD simulationĀ and MMPBSA analysis.
    Pasha MH; Gondal HY; Munir S; Alhussain SA; Zaki MEA
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400010. PubMed ID: 38578079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Potential Non-steroidal Aromatase Inhibitors for Therapeutic Application against Estrogen-dependent Breast Cancer.
    Pandey K; Bharat Lokhande K; Saha A; Goja A; Swamy KV; Nagar S
    Curr Comput Aided Drug Des; 2023; 19(4):243-257. PubMed ID: 36644872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors.
    Tripathi SK; Muttineni R; Singh SK
    J Theor Biol; 2013 Oct; 334():87-100. PubMed ID: 23727278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial.
    van Ommen-Nijhof A; Konings IR; van Zeijl CJJ; Uyl-de Groot CA; van der Noort V; Jager A; Sonke GS;
    BMC Cancer; 2018 Nov; 18(1):1146. PubMed ID: 30458732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment.
    Gobbi S; Martini S; Rozza R; Spinello A; Caciolla J; Rampa A; Belluti F; Zaffaroni N; Magistrato A; Bisi A
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications.
    Binmujlli MA
    Molecules; 2024 Sep; 29(17):. PubMed ID: 39275052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.